• Working with

    passion, integrity,
    & true innovation

  • Developing

    novel, first-in-class therapeutics

  • Targeting

    major unmet medical needs

  • Changing

    the approach to
    treating cancer

Imetelstat

First-in-class, first-in-clinic,
telomerase inhibitor

 

Telomerase

Learn about our innovative approach to developing a treatment for cancer

 

Geron Announces
Collaboration with Janssen

Click here for important information

 

Geron News

8.3.2016

Geron Corporation Reports Second Quarter 2016 Financial Results and Recent Events

Read More

7.27.2016

Geron Announces Conference Call to Discuss Second Quarter 2016 Financial Results

Read More

7.13.2016

Geron Announces Issuance of U.S. Patents Related to Imetelstat

Read More

 

Events

05.17.2016

Geron 2016 Annual Meeting

Learn more

05.05.2016

Geron Q1 2016 Conference Call

Listen to Webcast

04.12.2016

Geron at the 15th Annual Needham Healthcare Conference

Listen to Webcast

Download slides